No Decrease in Susceptibility to NVC-422 in Multiple-Passage Studies with Methicillin-Resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli

Multistep Resistance Development Studies of Ceftaroline in Gram-Positive and -Negative Bacteria

(2011) Catherine Clark et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Chemical Characterization and Biological Properties of NVC-422, a Novel, StableN-Chlorotaurine Analog

(2011) Lu Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis

(2011) Jungjoo Yoon et al.   ANTIVIRAL RESEARCH

Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics

(2011) José Luis Martínez et al.   CURRENT OPINION IN PHARMACOLOGY

Pseudomonas Aeruginosa: Resistance to the Max

(2011) Keith Poole   Frontiers in Microbiology

Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-ResistantStaphylococcus aureusIsolates during a 55-Passage Study

(2010) David J. Farrell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fusidic Acid Resistance Determinants in Staphylococcus aureus Clinical Isolates

(2010) H.-J. Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mupirocin Resistance

(2009) Jean B. Patel et al.   CLINICAL INFECTIOUS DISEASES

Genetic Characterization of Vga ABC Proteins Conferring Reduced Susceptibility to Pleuromutilins in Staphylococcus aureus

(2008) D. R. Gentry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines

(2008) Lu Wang et al.   TETRAHEDRON LETTERS